Improvement of risk assessment in systemic light-chain amyloidosis using human placental growth factor

Vascular amyloid deposition is common in light-chain amyloidosis resulting in endothelial dysfunction. Human placental growth factor (PlGF), a member of the vascular endothelial growth factor family was found to be altered in diverse pathological conditions, e.g. endothelial dysfunction. This study...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kristen, Arnt (VerfasserIn) , Rinn, Johannes (VerfasserIn) , Hegenbart, Ute (VerfasserIn) , Lindenmaier, David (VerfasserIn) , Merkle, Corina (VerfasserIn) , Röcken, Christoph (VerfasserIn) , Hardt, Stefan (VerfasserIn) , Giannitsis, Evangelos (VerfasserIn) , Katus, Hugo (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2015
In: Clinical research in cardiology
Year: 2015, Jahrgang: 104, Heft: 3, Pages: 250-257
ISSN:1861-0692
DOI:10.1007/s00392-014-0779-y
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00392-014-0779-y
Verlag, lizenzpflichtig, Volltext: https://link.springer.com/article/10.1007%2Fs00392-014-0779-y
Volltext
Verfasserangaben:Arnt V. Kristen, Johannes Rinn, Ute Hegenbart, David Lindenmaier, Corina Merkle, Christoph Röcken, Stefan Hardt, Evangelos Giannitsis, Hugo A. Katus
Beschreibung
Zusammenfassung:Vascular amyloid deposition is common in light-chain amyloidosis resulting in endothelial dysfunction. Human placental growth factor (PlGF), a member of the vascular endothelial growth factor family was found to be altered in diverse pathological conditions, e.g. endothelial dysfunction. This study evaluated the clinical role of PlGF in light-chain amyloidosis.
Beschreibung:Published online: 21 October 2014
Gesehen am 29.05.2020
Beschreibung:Online Resource
ISSN:1861-0692
DOI:10.1007/s00392-014-0779-y